Markets:

Overview

News

Currencies

International

Treasuries

Ocular Therapeutix, Inc. - Common Stock (NQ:OCUL)

7.030 +0.150 (+2.18%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ocular Therapeutix, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

2 Small-Cap Growth Stocks With Room To Run ↗

April 24, 2024

These two small-cap growth stocks could be ready to run.

Via The Motley Fool

Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 19, 2024

Via Benzinga

Ocular Therapeutix Highlights Early Data From Diabetes-Related Eye Disorder ↗

April 18, 2024

Ocular Therapeutix's Phase 1 HELIOS study unveils Axpaxli's efficacy in treating non-proliferative diabetic retinopathy. Significant DRSS improvement with no worsening observed. Positive Phase 2 data...

Via Benzinga

Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 18, 2024

Via Benzinga

The Analyst Verdict: Ocular Therapeutix In The Eyes Of 8 Experts ↗

April 16, 2024

Via Benzinga

The 3 Best Biotech Stocks to Buy Now: Q2 Edition ↗

April 16, 2024

Investors can find some of the hottest, most explosive opportunities in these three top biotech stocks to buy now.

Via InvestorPlace

Biotech on a Budget: 7 Stocks Under $10 With Huge Potential ↗

April 15, 2024

With the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks.

Via InvestorPlace

Million-Dollar Bets: 3 Under-$15 Stocks With Massive Potential ↗

April 01, 2024

Here are three under-$15 stocks with massive potential based on their strategic moves in the pharmaceuticals and banking industries.

Via InvestorPlace

Decoding 6 Analyst Evaluations For Ocular Therapeutix ↗

March 13, 2024

Via Benzinga

These Analysts Boost Their Forecasts On Ocular Therapeutix After Q4 Results ↗

March 12, 2024

Ocular Therapeutix, Inc. (NASDAQ: OCUL) reported worse-than-expected fourth-quarter financial results on Monday.

Via Benzinga

Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

March 12, 2024

Shares of Oracle Corporation (NYSE: ORCL) rose sharply in today’s pre-market trading after the company reported upbeat earnings for its fis

Via Benzinga

Ocular Therapeutix: Q4 Earnings Insights ↗

March 11, 2024

Via Benzinga

Earnings Outlook For Ocular Therapeutix ↗

March 08, 2024

Via Benzinga

Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 12, 2024

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.

Via Benzinga

ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

March 12, 2024

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 11, 2024

Via Benzinga

Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket ↗

March 11, 2024

Shares of Fangdd Network Group Ltd. (NASDAQ: DUO) rose sharply in today’s pre-market trading after the company announced its 2024 strategic layout with plans to enter the real estate stock asset...

Via Benzinga

Earnings Scheduled For March 11, 2024 ↗

March 11, 2024

Companies Reporting Before The Bell • Ballard Power Systems (NASDAQ:BLDP) is estimated to report quarterly loss at $0.13 per share on revenue of $34.20 million.

Via Benzinga

$7M Bet On Ocular Therapeutix? Check Out These 3 Stocks Insiders Are Buying ↗

February 28, 2024

Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.

Via Benzinga

Piper Sandler Maintains Overweight Rating for Ocular Therapeutix: Here's What You Need To Know ↗

February 26, 2024

Via Benzinga

3 Stocks to Buy That Are Up 100% or More in 2024 ↗

February 25, 2024

While stocks up 100% don’t seem like a particularly great deal, these high-flying entities can still provide more rewards.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 22, 2024

Via Benzinga

NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday ↗

February 22, 2024

U.S. stocks were higher, with the Nasdaq Composite gaining more 2% on Thursday.

Via Benzinga

Topics Stocks

Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 22, 2024

Shares of Etsy, Inc.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 22, 2024

Via Benzinga

SPS Commerce Posts Upbeat Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Friday ↗

February 09, 2024

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 100 points on Friday. Shares of SPS Commerce, Inc. (NASDAQ: SPSC) rose sharply during Friday’s session following upbeat results.

Via Benzinga

Topics Stocks

Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

February 09, 2024

Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results.

Via Benzinga

Wall Street Thinks These 2 Biotech Stocks Could Soar in 2024 ↗

January 03, 2024

These two biotech stocks sport notable 12-month price targets. However, they are also uber-risky.

Via The Motley Fool

Why Nxu Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket ↗

December 14, 2023

Shares of Nxu, Inc. (NASDAQ: NXU) rose sharply in pre-market trading after the company signed a letter of intent outlining investment in Lynx Motors. Nxu, shares rose 42.1% to $0.0278 in pre-market...

Via Benzinga

Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

December 14, 2023

Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Ocular Therapeutix, Inc. - Common Stock (NQ:OCUL)

All News about Ocular Therapeutix, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today